Edema other names, affected parts, treatment & home remedies
Jambul Fruits : Botanical Name, Distribution, Cultivation, Common names and Synonyms
Mexican pharma company Sanfer secures $500m investment from CDPQ
CDPQ investment in Sanfer : Mexican pharma company Sanfer has secured a $500 million minority investment from Canadian long-term institutional investor Caisse de dépôt et placement du Québec (CDPQ) to help it execute its continued expansion plans across Mexico and the Latin American region. In the last 20 years, Sanfer claims to have closed more than […]
The post Mexican pharma company Sanfer secures $500m investment from CDPQ appeared first on PharmaNewsDaily.com.
Soybean health benefits | Soybean benefits for health
Nabriva secures Xenleta FDA approval for community-acquired pneumonia
Xenleta FDA approval : Irish pharma company Nabriva Therapeutics has bagged approval from the US Food and Drug Administration for its semi-synthetic pleuromutilin antibiotic Xenleta (lefamulin) for the treatment of community-acquired bacterial pneumonia in adults. Community-acquired pneumonia is caused when someone develops pneumonia in the community, that is not in a hospital. Pneumonia is a […]
The post Nabriva secures Xenleta FDA approval for community-acquired pneumonia appeared first on PharmaNewsDaily.com.
Skeletal System – Bones Structure and functions, composition
Know about headache & migraine, symptoms, causes
Celgene bags Inrebic FDA approval for myelofibrosis
Inrebic FDA approval : Celgene’s subsidiary Impact Biomedicines, has bagged approval for its oral kinase inhibitor Inrebic (fedratinib) capsules from the US Food and Drug Administration (FDA) for the treatment of certain types of myelofibrosis, a rare bone marrow cancer. Fedratinib FDA approval is for the treatment of adult patients with intermediate-2 or high-risk primary […]
The post Celgene bags Inrebic FDA approval for myelofibrosis appeared first on PharmaNewsDaily.com.
Alfasigma USA launches IBS-C drug ZELNORM in US
Alfasigma USA has launched ZELNORM (tegaserod) tablets in the US as a prescription drug for irritable bowel syndrome with constipation (IBS-C) in adult women aged under 65 years. ZELNORM was acquired by Alfasigma USA in July 2019 from Sloan Pharma, a subsidiary of US WorldMeds. Bryan Downey – president and CEO of Alfasigma USA said: “We […]
The post Alfasigma USA launches IBS-C drug ZELNORM in US appeared first on PharmaNewsDaily.com.
AbbVie secures Rinvoq FDA approval for rheumatoid arthritis
Rinvoq FDA approval : US biopharma company AbbVie has bagged approval from the US Food and Drug Administration (FDA) for its 15mg, daily once oral, small molecule Janus kinase (JAK) inhibitor – Rinvoq (upadacitinib) for the treatment of moderately to severely active rheumatoid arthritis (RA). The FDA approval for Rinvoq is for the treatment of […]
The post AbbVie secures Rinvoq FDA approval for rheumatoid arthritis appeared first on PharmaNewsDaily.com.